Austin Health

Title
Identification of Potential Biomarkers for Cancer Cachexia and Anti-Fn14 Therapy.
Publication Date
2022-11-10
Author(s)
Cao, Zhipeng
Burvenich, Ingrid J
Zhao, Kening
Senko, Clare
Glab, Jason
Fogliaro, Renee
Liu, Zhanqi
Jose, Irvin
Puthalakath, Hamsa
Hoogenraad, Nick J
Osellame, Laura D
Scott, Andrew M
Subject
LCN2
RNA-seq
biomarker
cancer cachexia
Type of document
Journal Article
OrcId
0000-0003-4142-6190
0000-0001-8384-2403
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
0000-0002-8039-8391
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
DOI
10.3390/cancers14225533
Abstract
Developing therapies for cancer cachexia has not been successful to date, in part due to the challenges of achieving robust quantitative measures as a readout of patient treatment. Hence, identifying biomarkers to assess the outcomes of treatments for cancer cachexia is of great interest and important for accelerating future clinical trials.
Link
Citation
Cancers 2022; 14(22)
Jornal Title
Cancers

Files:

NameSizeformatDescriptionLink